|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 9.300 SEK | -6.06% |
|
-25.90% | -53.03% |
| 09-22 | 16 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-17 | Annexin Pharmaceuticals Doses First Patient in Expanded Retinal Vein Occlusion Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.06% | -25.90% | -29.55% | -26.48% | -53.03% | -68.37% | -86.68% | -94.97% | - | 7.05M | |
| -3.30% | +2.97% | -0.28% | +52.76% | +79.17% | +54.99% | +104.15% | +8.05% | - | 74.18B | |
| -0.12% | -1.63% | -7.45% | +2.68% | +16.46% | +33.14% | +74.86% | +209.19% | +5,410.23% | 59.55B | |
| +2.71% | -0.84% | -3.36% | +18.99% | -30.16% | -16.39% | +364.46% | +340.72% | +723.51% | 25.84B | |
| +0.81% | +3.58% | -14.85% | +9.53% | +4.26% | +1.01% | -5.14% | -71.88% | - | 24.73B | |
| -1.05% | +2.58% | +5.44% | +32.75% | +11.89% | +24.27% | -10.32% | -19.77% | +98.43% | 20.87B | |
| -1.70% | -4.15% | -17.50% | +17.01% | +172.60% | +147.82% | +325.69% | +1,373.37% | +610.90% | 15.32B | |
| +2.15% | +2.06% | +7.16% | +12.87% | +32.22% | +45.57% | +169.79% | +182.68% | +289.19% | 14.06B | |
| -0.43% | -5.32% | +24.47% | +14.95% | -6.35% | -14.46% | +775.94% | +204.46% | +87.63% | 13.12B | |
| +0.04% | -3.00% | -0.68% | -0.04% | -11.87% | +15.76% | +234.69% | +504.06% | +4,305.24% | 11.85B | |
| -1.33% | +0.43% | -24.15% | -17.31% | -0.48% | +103.29% | +142.55% | +2.12% | +815.10% | 9.46B | |
| +0.12% | +9.23% | +10.91% | +18.03% | +336.36% | +233.59% | +423.64% | -19.33% | - | 9.15B | |
| -0.23% | -5.38% | -14.55% | -17.94% | +3.34% | +35.24% | +112.15% | +95.36% | +649.54% | 9.15B | |
| +0.72% | -3.18% | -9.13% | +9.51% | +23.32% | +71.64% | +8.48% | +117.34% | - | 8.41B | |
| -1.22% | -4.48% | -18.22% | -10.26% | +165.84% | +443.63% | +634.32% | -55.17% | -46.32% | 7.77B | |
| +0.46% | +0.14% | +5.20% | +16.78% | +5.93% | +138.48% | +437.90% | - | - | 6.79B | |
| -7.29% | +4.74% | -10.54% | +18.86% | +0.07% | -1.10% | +197.86% | +264.92% | - | 7.54B | |
| -2.03% | +3.37% | -6.87% | -8.55% | -1.75% | +7.65% | +46.40% | +5.11% | +141.26% | 6.68B | |
| -4.89% | -3.87% | -16.71% | +7.82% | +196.68% | +477.92% | - | - | - | 5.95B | |
| -2.49% | -1.54% | -13.96% | -5.19% | +10.35% | +44.03% | +664.31% | +45.71% | - | 6.07B | |
| Average | -1.26% | -1.39% | -6.73% | +7.34% | +47.74% | +88.89% | +242.90% | +171.78% | +1,189.52% | 16.83B | |
| Weighted average by Cap. | -0.93% | -0.13% | -4.20% | +18.34% | +45.02% | +61.35% | +186.54% | +171.48% | +2,182.92% |
- Stock Market
- Stocks
- ANNX Stock
- Sector Annexin Pharmaceuticals AB
Select your edition
All financial news and data tailored to specific country editions
